Furthermore, MIR133B was found to inhibit PKHD1, which suppresses the proliferation of thyroid cancer cells and promotes the death of cancer cells [53], but its expression is low in early-stage PTC. This evidence concerns the gene PKHD1 and thyroid gland carcinoma.